Ahmednagar, India

Atul Kashinath Hajare

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atul Kashinath Hajare. Retrieved from https://idiyas.com/inventor/atul-kashinath-hajare

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0


 

Average Co-Inventor Count = 13.0

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Maharashtra, IN (2012)
  • Ahmednagar, IN (2013 - 2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Atul Kashinath Hajare

Introduction

Atul Kashinath Hajare is a notable inventor hailing from Ahmednagar, India. With a remarkable portfolio of five patents, he has made significant contributions to the field of medicine, specifically in the area of treating conditions related to diabetes. His work is characterized by a commitment to innovation and a desire to improve patient outcomes through advanced therapeutic solutions.

Latest Patents

Among Atul's noteworthy inventions is his latest patent titled "Glycoside derivatives and uses thereof." This innovative concept involves compounds represented by a specific formula that are useful for treating diseases mediated by the sodium D-glucose co-transporter (SGLT), particularly diabetes. The patent outlines methods for treating such conditions, along with compositions that facilitate their management. The repetition of this invention emphasizes its significance, highlighting the ongoing efforts to address pressing health issues through innovative solutions.

Career Highlights

Atul Kashinath Hajare currently works with Novartis AG, a global healthcare company recognized for its contributions to pharmaceuticals and biotechnology. His tenure at Novartis reflects his engagement in cutting-edge research and development, allowing him to hone his skills as an inventor and drive forward impactful innovations.

Collaborations

Throughout his career, Atul has collaborated with esteemed colleagues such as Gregory Raymond Bebernitz and Mark G Bock. These collaborations signify a collective effort in advancing medicinal sciences, showcasing the importance of teamwork in the process of invention and innovation.

Conclusion

Atul Kashinath Hajare stands out as an influential inventor in the realm of glycoside derivatives targeted at diabetes treatment. His commitment to innovation is reflected in his patents, collaborations, and contributions to Novartis AG. As the field of medicine continues to evolve, inventors like Atul play a crucial role in driving progress and enhancing therapeutic options for patients around the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…